Mm. Ismail et al., EFFICACY OF SINGLE-DOSE COMBINATIONS OF ALBENDAZOLE, IVERMECTIN AND DIETHYLCARBAMAZINE FOR THE TREATMENT OF BANCROFTIAN FILARIASIS, Transactions of the Royal Society of Tropical Medicine and Hygiene, 92(1), 1998, pp. 94-97
Citations number
22
Categorie Soggetti
Public, Environmental & Occupation Heath","Tropical Medicine
In a 'blind' trial on 50 male asymptomatic microfilaraemic subjects wi
th Wuchereria bancrofti infection, the safety, tolerability and filari
cidal efficacy of a single dose of albendazole (alb) 600 mg alone or i
n combination with ivermectin liver) 400 mu g/kg or diethylcarbamazine
citrate (DEC) 6 mg/kg was compared with a single dose of the combinat
ion DEC 6 mg/kg and iver 400 mu g/kg over a period of 15 months after
treatment. All but one subject, with 67 microfilariae (mf)/mL, had pre
-treatment counts >100 mf/mL. All 4 treatments significantly reduced m
f counts, but alb/iver was the most effective regimen for clearing mf
from night blood: 9 of 13 subjects (69%) were amicrofilaraemic by memb
rane filtration 15 months after treatment compared to one of 12 (8%),
3 of 11 (27%), and 3 of 10 (30%) in the groups treated with alb, alb/D
EC, and DEC/iver, respectively. Filarial antigen tests suggested that
all 4 treatments had significant activity against adult W. bancrofti;
alb/DEC had the greatest activity according to this test, with antigen
levels decreasing by 77% 15 months after therapy. All 4 regimens were
well tolerated and clinically safe, although mild, self-limited syste
mic reactions were observed in all treatment groups. These results sug
gest that alb/iver is a safe and effective single dose regimen for sup
pression of microfilaraemia in bancroftian filariasis that could be co
nsidered for control programmes. Additional benefits of this combinati
on are its potent, broad spectrum activity against intestinal helminth
s and potential relative safety in areas of Africa where DEC cannot be
used for filariasis control because of co-endemicity with onchocercia
sis or loiasis.